Amarin (AMRN) Publishes Additional Data for MARINE, ANCHOR Phase 3s

January 22, 2013 7:31 AM EST Send to a Friend
Amarin Corp Plc (Nasdaq: AMRN) that additional data from its pivotal MARINE and ANCHOR Phase 3 clinical trials are now ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login